Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine whether Panax Ginseng with multiple interactions
with key components of brain signaling pathway, can augment the effects of antipsychotics in
Schizophrenia. We are primarily interested to examine the actions of Ginseng combined with
antipsychotics in improving the ways patients diagnosed with schizophrenia behave in social
environment, store, process and retrieve information.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Lawson Health Research Institute
Collaborators:
Imperial College London Northern Ontario School of Medicine Queen's University